Colin Steen, one of Syngenta Ventures' managing directors, has departed from the unit after more than two years for a chief executive role elsewhere.
Colin Steen (pictured) has left Switzerland-based agribusiness Syngenta’s corporate venturing unit, Syngenta Ventures, to become CEO of US-headquartered seed producer Legacy Seed Companies.
Steen had been managing director at the unit for more than two and a half years following the departure of Derek Norman to Bayer. He held a board seat at portfolio company Premier Crop Systems and a board observer role at Greenlight Bio. David Pierson, Jason Gabriel and Shubhang Shankar, the other MDs at Syngenta Ventures, remain…
